L&C Bio

290650.KQ

46.99 USD

3.79

+8.77%

Overview

Last close

46.99 usd

Market cap

1.14B usd

52 week high

81.75 usd

52 week low

10.84 usd

Target price

53.88 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

19.8285

Price/Book Value

8.5503

Enterprise Value

1.18B usd

EV/Revenue

20.4764

EV/EBITDA

12.6876

Key financials

Revenue TTM

57.57M usd

Gross Profit TTM

30.57M usd

EBITDA TTM

7.85M usd

Earnings per Share

N/A usd

Dividend

0.03 usd

Total assets

316.51M usd

Net debt

38.50M usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Symbol
290650.KQ
Exchange
KQ
Isin
KR7290650001
Country
South Korea
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Chul Lee Whan
Headquarter
Seongnam-si
Web site
https://www.lncbio.co.kr

Related indices

JAKOTA Mid and Small Cap 2000 Index

180.75 +0.08%